Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Risk Factors for Occurrence and Outcome of Acute Graft Versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: Analysis of 7 Year Health Care Utilization Project Data

Nauman Saleem Siddiqui, MD, Mohammad Saud Khan, MD, Zubair Khan, MD, Hermann Simo, MD, Jamal Mohamad Saleh, MD, Kellie Sprague, MD

Blood (2017) 130 (Supplement 1): 4493.

https://doi.org/10.1182/blood.V130.Suppl_1.4493.4493

Published: 2017

Journal Articles

Risk-Adapted Melphalan and Stem Cell Transplantation after Suboptimal Responses to Bortezomib-Based Initial Therapy in Patients with Systemic Light-Chain Amyloidosis (AL)

Sandy W. Wong, MD, Denise Larivee, RN, Melissa Warner, BS, Kellie Sprague, MD, Terry Fogaren, RN, BSN, Raymond L. Comenzo, MD

Blood (2016) 128 (22): 5831.

https://doi.org/10.1182/blood.V128.22.5831.5831

Published: 2016

Journal Articles

Improvements in Patient Outcomes with Autologous Stem Cell Transplantation for Multiple Myeloma over 25 Years at a Single Center

Sandy W. Wong, MD, Melissa Warner, BS, Alejandro Moreno-Koehler, MPH, Athena Kritharis, MD, Michael E Coyle, MD, Deborah Black, RN, BSN, Valerie Relias, PharmD, BCOP, Terry Fogaren, RN, BSN, Nancy Cody Lyons, NP, Francois Toka, NP-C, Denise Larivee, RN, Hedy Smith, MD PhD, Andrew M. Evens, DO, MSc, Grace Kao, MD, Kellie Sprague, MD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Raymond L. Comenzo, MD

Blood (2015) 126 (23): 5496.

https://doi.org/10.1182/blood.V126.23.5496.5496

Published: 2015

Journal Articles

Colchicine Can be an Effective Adjunctive Treatment for Extensive Refractory Chronic-Graft-Versus-Host Disease

Sandy W. Wong, MD, Raymond L. Comenzo, MD, Todd F. Roberts, MD MSC, FRCP (C), Kellie Sprague, MD, Kenneth B. Miller, MD

Blood (2015) 126 (23): 5461.

https://doi.org/10.1182/blood.V126.23.5461.5461

Published: 2015

Journal Articles

Clinicopathologic Characteristics Of Secondary Malignancies In Survivors Of Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Malignancies

Chakra P Chaulagain, MD, FACP, Esha Kaul, MD, Monika Pilichowska, MD, Andreas K. Klein, MD, Kellie Sprague, MD, Kenneth B. Miller, MD

Blood (2013) 122 (21): 5496.

https://doi.org/10.1182/blood.V122.21.5496.5496

Published: 2013

Journal Articles

Cost-Implications Of Comorbidity For Autologous Hematopoietic Stem Cell Transplantation (Auto HSCT) In Elderly Patients With Multiple Myeloma (MM) Using The SEER-Medicare Database

Gunjan L. Shah, MD MS, Aaron Winn, MPP, Andreas K. Klein, MD, Kellie Sprague, MD, Joshua T. Cohen, PhD, Kenneth B. Miller, MD, Susan K. Parsons, MD, MRP

Blood (2013) 122 (21): 1746.

https://doi.org/10.1182/blood.V122.21.1746.1746

Published: 2013

Journal Articles

Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Patients ≥ 60 Years of Age with a Novel Reduced Intensity Conditioning Regimen Incorporating Extracorporeal Photopheresis,

Furha I. Cossor, MD, Sandy Wong, MD, Kenneth B Miller, MD, Deborah Black, RN, Raymond L. Comenzo, MD, Andreas K. Klein, MD, Alanna Klekar, RN, Valerie Relias, PharmD, Hedy Smith, MD, PhD, Kellie Sprague, MD, Karen M Switkowski, MS, MPH, Richard A. Van Etten, MD PhD, Hans-Georg Klingemann, MD, PhD

Blood (2011) 118 (21): 4153.

https://doi.org/10.1182/blood.V118.21.4153.4153

Published: 2011

Journal Articles

Clofarabine for Cytoreduction Prior to Allogeneic Transplant Conditioning for Refractory Acute Myelogenous Leukemia

Deepa Jeyakumar, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Andreas K. Klein, MD, Hans-Georg Klingemann, MD, PhD

Blood (2011) 118 (21): 4506.

https://doi.org/10.1182/blood.V118.21.4506.4506

Published: 2011

Journal Articles

Targeting CXCR4 with Cell-Penetrating Pepducins Enhances Survival in Disseminated Lymphoma

Lidija Covic, Katie M O’Callaghan, PhD, Nga Ngyen, Hsieh Mo-Ying, Andreas K. Klein, MD, Kellie Sprague, MD, Richard A. Van Etten, MD PhD, Athan Kuliopulos, MD, PhD

Blood (2011) 118 (21): 4244.

https://doi.org/10.1182/blood.V118.21.4244.4244

Published: 2011

Journal Articles

Allogeneic NK Cell Therapy After Autologous Stem Cell Transplant: Results of a Phase I Study

Hans-Georg Klingemann, MD, PhD, Carrie Grodman, RN, Andreas K. Klein, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Tarun Kewalramani, MD, Raymond L. Comenzo, MD, Neng Yu, MD, Marvin Duque, MD, Richard A. Van Etten, MD, PhD, David McKenna, MD

Blood (2010) 116 (21): 4299.

https://doi.org/10.1182/blood.V116.21.4299.4299

Published: 2010

Journal Articles

Mitoxantrone and Melphalan Conditioning Regimen for Autologous Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia.

Kellie Sprague, MD, Vaishalee Padgaonkar, MD, Andreas K. Klein, MD, Geoffrey W. Chan, MD, Kenneth B. Miller, MD, Hans Klingemann, MD/PhD

Blood (2005) 106 (11): 5512.

https://doi.org/10.1182/blood.V106.11.5512.5512

Published: 2005

Journal Articles

Allogeneic Stem Cell Transplant (AlloSCT) for Hodgkin’s Lymphoma Which Has Relapsed Following Autologous SCT - Evidence for Potent Graft-Versus-Lymphoma Effect.

Andreas K. Klein, MD, Chan Geoffrey, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Francine Foss, MD

Blood (2004) 104 (11): 3327.

https://doi.org/10.1182/blood.V104.11.3327.3327

Published: 2004

Journal Articles

Cytomegalovirus Reactivation and Relapse Following Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning Regimen.

Revati Rao, MD, Kevin Chin, MD, Geoff Chan, MD, Kellie Sprague, MD, Andreas Klein, MD, Kenneth B. Miller, MD, Francine Foss, MD, David R. Snydman, MD

Blood (2004) 104 (11): 5104.

https://doi.org/10.1182/blood.V104.11.5104.5104

Published: 2004

NARROW

Risk Factors for Occurrence and Outcome of Acute Graft Versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: Analysis of 7 Year Health Care Utilization Project Data

Risk-Adapted Melphalan and Stem Cell Transplantation after Suboptimal Responses to Bortezomib-Based Initial Therapy in Patients with Systemic Light-Chain Amyloidosis (AL)

Improvements in Patient Outcomes with Autologous Stem Cell Transplantation for Multiple Myeloma over 25 Years at a Single Center

Colchicine Can be an Effective Adjunctive Treatment for Extensive Refractory Chronic-Graft-Versus-Host Disease

Clinicopathologic Characteristics Of Secondary Malignancies In Survivors Of Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Malignancies

Cost-Implications Of Comorbidity For Autologous Hematopoietic Stem Cell Transplantation (Auto HSCT) In Elderly Patients With Multiple Myeloma (MM) Using The SEER-Medicare Database

Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Patients ≥ 60 Years of Age with a Novel Reduced Intensity Conditioning Regimen Incorporating Extracorporeal Photopheresis,

Clofarabine for Cytoreduction Prior to Allogeneic Transplant Conditioning for Refractory Acute Myelogenous Leukemia

Targeting CXCR4 with Cell-Penetrating Pepducins Enhances Survival in Disseminated Lymphoma

Allogeneic NK Cell Therapy After Autologous Stem Cell Transplant: Results of a Phase I Study

Mitoxantrone and Melphalan Conditioning Regimen for Autologous Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia.

Allogeneic Stem Cell Transplant (AlloSCT) for Hodgkin’s Lymphoma Which Has Relapsed Following Autologous SCT - Evidence for Potent Graft-Versus-Lymphoma Effect.

Cytomegalovirus Reactivation and Relapse Following Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning Regimen.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only